Neurodevelopmental Disorders: From Pathophysiology to Novel Therapeutic Approaches—2nd Edition
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".
Deadline for manuscript submissions: 31 March 2025 | Viewed by 2906
Special Issue Editors
2. TRE Unit, Division of Psychiatric Specialties, Department of Psychiatry, University Hospital of Geneva, Geneva, Switzerland
Interests: ADHD; personality disorders from diagnosis to treatment
Interests: clinically oriented research in treatment-resistant depression; autism spectrum disorder and intellectual disability; main topics include diagnosis, treatment, genetics and neuroimaging
Special Issue Information
Dear Colleagues,
The DSM-5, introduced in 2013, has allowed for a renewed appreciation of the longitudinal, whole-life perspective of neurodevelopmental disorders in psychiatry, including autism spectrum disorder (ASD) and other communication, speech and language disorders and attention-deficit/hyperactivity disorder (ADHD), intellectual disability (ID), as well as other specific learning disorders.
However, our understanding of the basic aspects of the pathophysiology of these disorders and efficient therapies is still incomplete. The adult population suffering from these disorders is especially widely under-researched and rarely benefits from adequate treatments.
In this Special Issue of Biomedicines, we aim to present the actual state of the art in the understanding of the pathophysiology of neurodevelopmental disorders and their treatments, from birth to the end of life.
Dr. Nader Perroud
Dr. Markus Mathaus Kosel
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- intellectual disability
- autism spectrum disorder
- attention-deficit/hyperactivity disorder
- drug treatment
- neuroimaging
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
